A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes-Reference-Cited by-同舟云学术

A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes

Published:1998-12 Issue:4 Volume:103 Page:1070-1074
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1998.01085.x/fullpdf

Reference26 articles.

1. Proposals for the classification of the myelodysplastic syndromes

2. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia

3. The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin

4. NEW TOOLS FOR CLINICAL EVALUATION OF ERYTHRON FUNCTION IN MAN

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Literature Review of Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes;Journal of Clinical Medicine;2024-05-04

2. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2022-06-20

3. Myelodysplasia;Pathy's Principles and Practice of Geriatric Medicine;2022-02-18

4. Stanozolol for the treatment of anemic lower-risk myelodysplastic syndromes without del(5q) after failure of epoetin alfa: findings from a retrospective study;Annals of Hematology;2021-04-10

5. Treatment of Acquired Sideroblastic Anemias;Hematology/Oncology Clinics of North America;2020-04